Financial Ratios

MARKSANS PHARMA LTD.

NSE : MARKSANSBSE : 524404ISIN CODE : INE750C01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE169.301.45 (+0.86 %)
PREV CLOSE ( ) 167.85
OPEN PRICE ( ) 169.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 144938
TODAY'S LOW / HIGH ( )167.25 171.85
52 WK LOW / HIGH ( )70.2 185.4
NSE169.801.75 (+1.04 %)
PREV CLOSE( ) 168.05
OPEN PRICE ( ) 169.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 169.80 (1464)
VOLUME 1703066
TODAY'S LOW / HIGH( ) 167.00 171.95
52 WK LOW / HIGH ( )70.55 185.5
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.272.542.400.931.07
   CEPS(Rs)2.642.972.771.211.28
   DPS(Rs)0.500.250.250.100.05
   Book NAV/Share(Rs)24.5216.9014.6512.3511.50
   Tax Rate(%)22.0922.6920.8728.1122.13
Margin Ratios
   Core EBITDA Margin(%)13.2117.0918.8216.4914.93
   EBIT Margin(%)19.5020.7921.4613.8514.75
   Pre Tax Margin(%)18.9820.2220.5812.1713.21
   PAT Margin (%)14.7915.6316.288.7510.28
   Cash Profit Margin (%)17.1918.2918.8011.4312.33
Performance Ratios
   ROA(%)8.6911.8814.356.147.36
   ROE(%)11.4116.1117.807.779.70
   ROCE(%)14.2719.9123.4611.3911.99
   Asset Turnover(x)0.590.760.880.700.72
   Sales/Fixed Asset(x)2.242.302.301.831.99
   Working Capital/Sales(x)1.001.572.382.482.85
Efficiency Ratios
   Fixed Capital/Sales(x)0.450.430.440.550.50
   Receivable days144.90114.0399.91143.04149.17
   Inventory Days61.5654.1450.8361.0448.47
   Payable days86.0766.9965.2569.8154.75
Valuation Parameters
   PER(x)31.0517.9320.7815.0123.32
   PCE(x)26.7115.3318.0011.4819.45
   Price/Book(x)2.872.703.411.132.16
   Yield(%)0.710.550.500.720.20
   EV/Net Sales(x)4.202.503.231.312.58
   EV/Core EBITDA(x)18.0710.5513.387.8915.34
   EV/EBIT(x)20.3011.9014.959.4217.47
   EV/CE(x)2.001.662.550.931.75
   M Cap / Sales4.882.833.411.312.40
Growth Ratio
   Net Sales Growth(%)-0.479.8038.332.1843.95
   Core EBITDA Growth(%)-2.307.66102.150.5694.84
   EBIT Growth(%)-1.926.65116.06-4.08157.25
   PAT Growth(%)-1.085.70159.56-13.10250.98
   EPS Growth(%)-10.655.70159.57-13.10250.99
Financial Stability Ratios
   Total Debt/Equity(x)0.000.010.000.000.17
   Current Ratio(x)3.893.222.853.192.10
   Quick Ratio(x)3.352.682.172.261.58
   Interest Cover(x)37.5436.4424.268.239.54
   Total Debt/Mcap(x)0.000.000.000.08

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.